FdaApplication
ANDA 062727
Identifiers
- fda_app_no: ANDA062727
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | ANDA |
| approval_date | 1986-12-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOTACILLIN-N | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| TOTACILLIN-N | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
2 products